SEC Form 4 · accession 0001140361-16-057611
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis W Sullivan
Director
Period of report
Mar 10, 2016
Accepted (ET)
Mar 14, 2016 · 3:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 10, 2016 | M | 14,820 | $10.28 | A | 43,320 | D | |
| Common StockF1,F2 | Mar 10, 2016 | S | 14,820 | $35.34 | D | 28,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F3 | $10.28 | Mar 10, 2016 | M | 14,820 | D | — | Jun 29, 2016 | Common Stock | 14,820 | 14,879 | D |
Explanation of responses
- F1Consists of an option granted under the company's stock incentive plan on June 30, 2006.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.20 to $34.52, inclusive.
- F3The option vested in three equal installments in June 2007, 2008 and 2009.